USD 15.15
(0.83%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.56 Billion USD | -0.1% |
2022 | 2.56 Billion USD | 2.4% |
2021 | 2.5 Billion USD | 9.94% |
2020 | 2.28 Billion USD | -17.07% |
2019 | 2.75 Billion USD | -3.27% |
2018 | 2.84 Billion USD | 1.2% |
2017 | 2.81 Billion USD | 0.92% |
2016 | 2.78 Billion USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 623.6 Million USD | -3.41% |
2024 Q2 | 633.1 Million USD | 1.52% |
2024 Q3 | 601 Million USD | -5.07% |
2023 FY | 2.56 Billion USD | -0.1% |
2023 Q3 | 631.3 Million USD | -4.7% |
2023 Q2 | 662.4 Million USD | 5.61% |
2023 Q1 | 627.2 Million USD | -5.08% |
2023 Q4 | 645.6 Million USD | 2.27% |
2022 FY | 2.56 Billion USD | 2.4% |
2022 Q4 | 660.8 Million USD | 4.71% |
2022 Q3 | 631.1 Million USD | -2.28% |
2022 Q2 | 645.8 Million USD | 2.28% |
2022 Q1 | 631.4 Million USD | -3.13% |
2021 Q2 | 740.1 Million USD | 4.36% |
2021 FY | 2.5 Billion USD | 9.94% |
2021 Q3 | 607.3 Million USD | -17.94% |
2021 Q1 | 709.2 Million USD | -3.15% |
2021 Q4 | 651.8 Million USD | 7.33% |
2020 Q3 | 640.5 Million USD | 76.93% |
2020 Q4 | 732.3 Million USD | 14.33% |
2020 FY | 2.28 Billion USD | -17.07% |
2020 Q1 | 547.2 Million USD | -24.05% |
2020 Q2 | 362 Million USD | -33.85% |
2019 Q2 | 712.1 Million USD | 7.94% |
2019 FY | 2.75 Billion USD | -3.27% |
2019 Q3 | 659.3 Million USD | -7.41% |
2019 Q1 | 659.7 Million USD | -13.08% |
2019 Q4 | 720.5 Million USD | 9.28% |
2018 Q3 | 679.5 Million USD | -7.35% |
2018 Q1 | 672.6 Million USD | 0.0% |
2018 Q2 | 733.4 Million USD | 9.04% |
2018 Q4 | 759 Million USD | 11.7% |
2018 FY | 2.84 Billion USD | 1.2% |
2017 FY | 2.81 Billion USD | 0.92% |
2016 FY | 2.78 Billion USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Alcon Inc. | 10.09 Billion USD | 74.569% |
AptarGroup, Inc. | 3.48 Billion USD | 26.408% |
Baxter International Inc. | 14.81 Billion USD | 82.674% |
Becton, Dickinson and Company | 20.17 Billion USD | 87.281% |
Bausch + Lomb Corporation | 4.14 Billion USD | 38.097% |
Haemonetics Corporation | 1.3 Billion USD | -96.057% |
ResMed Inc. | 4.68 Billion USD | 45.222% |
Teleflex Incorporated | 2.97 Billion USD | 13.716% |
Warby Parker Inc. | 669.76 Million USD | -283.194% |
West Pharmaceutical Services, Inc. | 2.94 Billion USD | 12.994% |